Bydureon BCise and Ozempic come as a liquid in an injector pen. Both drugs are injected once per week. Ozempic pens contain multiple doses, depending on the weekly dose your doctor prescribes.

The Bydureon Pen is available as a 2mg strength pen in 4-count cartons. The Bydureon single-dose tray is still available for patients. For more information call (877) 700-7365 or visit Bydureon.com.

Bydureon BCise is available as a liquid suspension that’s injected under your skin.It comes in an autoinjector device. In the past, this drug was also available as Bydureon and Bydureon Pen.

The Bydureon Pen is a pre-filled, single-use pen injector that eliminates the need for patients to transfer medication from a vial into a syringe, according to Michele L. Meixell, AstraZeneca ...

The FDA approval of the Bydureon Pen offers a new treatment option for these patients, said Rich Daly, president, US Diabetes, AstraZeneca. The innovation is the latest in AstraZeneca's efforts to ...

BYDUREON is the first and only once-weekly medicine for adults with type 2 diabetes. The BYDUREON Pen is a pre-filled, single-use pen injector, eliminating the need for the patient to transfer the ...

Bydureon pen AstraZeneca announced data from a 10-week Phase 4 randomized, controlled, double-blind study assessing the quality of glucose control with Bydureon (exenatide extended-release) for ...

AstraZeneca won U.S. approval of its Bydureon pen for once-weekly treatment of Type 2 diabetes. The pen will be the first of its kind to hit the market. The prefilled, single-use pen injector ...

If you are overweight you may be prescribed Bydureon Bcise (Exenatide Extended Release). Although highly effective this injectable medication is not suitable for everyone. It is drug class, expensive ...

Bydureon, a glucagon-like peptide-1 receptor agonist, ... Meanwhile, Amylin intends to file for approval of Bydureon Pen in 2012 with a potential launch later this year/early next year.

Bydureon Pen (exenatide) had been due to reach the market at the end of 2012 or in early 2013, but was held up by an FDA request for more data. It will be launched onto the market later this year, ...

The US Food and Drug Administration (FDA) has approved extended-release exenatide in a pen form for the treatment of adults with type 2 diabetes, according to the manufacturer. AstraZeneca's ...